25 results on '"Park, Jinny"'
Search Results
2. Large-scale validation of the prediction model risk of bias assessment Tool (PROBAST) using a short form: high risk of bias models show poorer discrimination
3. Distinct genetic profile with recurrent population-specific missense variants in Korean adult atypical hemolytic uremic syndrome
4. A Prospective Phase III Trial for Comparing Cyclophosphamide and Fludarabine Conditioning Regimen in Severe Idiopathic Aplastic Anemia
5. THE GENERALIZABILITY OF CLINICAL PREDICTIVE MODELS FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE: RESULTS FROM INDEPENDENT EXTERNAL VALIDATIONS
6. Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System
7. Comprehensive geriatric assessment in elderly patients with newly diagnosed aggressive non-Hodgkin lymphoma treated with multi-agent chemotherapy
8. Comparison of Characteristics of Bacterial Bloodstream Infection between Adult Patients with Allogeneic and Autologous Hematopoietic Stem Cell Transplantation
9. Evaluation of Pre-Transplant Risk Factors of Bacterial Bloodstream Infection (BSI) in Patients with Hematopoietic Stem Cell Transplantation (HSCT) and Comparison of BSI Between Allogenic and Autologous HSCT
10. Ginseng saponin metabolite induces apoptosis in MCF-7 breast cancer cells through the modulation of AMP-activated protein kinase
11. Typhlitis due to mucormycosis after chemotherapy in a patient with acute myeloid leukemia
12. Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancer
13. Prospective Pilot Study of Consolidation Chemotherapy With Docetaxel and Cisplatin After Concurrent Chemoradiotherapy for Advanced Head and Neck Cancer
14. Nongastric marginal zone B-cell lymphoma: A prognostic model from a retrospective multicenter study
15. P3-129: Second–line therapy with irinotecan or gefitinib in pretreated patients with non–small cell lung cancer: final results of a new treatment strategy according to clinical predictors for response
16. P1-207: Concurrent chemoradiotherapy with irinotecan/cisplatin followed by consolidation chemotherapy with irinotecan/cisplatin in patients with limited-disease small cell lung cancer
17. P1-226: Irinotecan plus carboplatin for patients with extensive-disease small cell lung cancer
18. P3-128: Correlation of the epidermal growth factor receptor mutations with clinical outcomes in patients with non–small cell lung cancer treated gefitinib: an exploratory molecular analysis of a prospective phase II study
19. Up-regulation of PI3K/Akt signaling by 17β-estradiol through activation of estrogen receptor-α, but not estrogen receptor-β, and stimulates cell growth in breast cancer cells
20. Dimethylsulfoxide induces upregulation of tumor suppressor protein PTEN through nuclear factor-κB activation in HL-60 cells
21. A phase II trial of concurrent chemoradiation therapy followed by consolidation chemotherapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancers
22. P-59 Early concurrent chemoradiotherapy with oral etoposide and cisplatin for limited-stage small-cell lung cancer
23. P-620 Gefitinib (‘Iressa’, ZD1839) monotherapy as a salvage regimen for previously treated advanced non-small-cell lung cancer (NSCLC)
24. P-597 A phase II trial of concurrent chemoradiation therapy followed by consolidation chemotherapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancer (NSCLC)
25. P-566 Salvage chemotherapy for relapsed or refractory small-cell lung cancer: prognostic factors of survival following salvage chemotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.